Point72 Hong Kong LTD Mustang Bio, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $1,346 - $2,301	-446 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $1,186 - $1,864	446 New	446 $2,000
Q3 2020 Nov 16, 2020	SELL	$3.01 - $3.88 $16,576 - $21,367	-5,507 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $12,831 - $25,332	5,507 New	5,507 $18,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.